Pfizer (NYSE:PFE) discovers, develops, manufactures, markets, distributes and sells biopharmaceutical products in the United ...

As was the case with Ares Capital and Enterprise Products Partners, Pfizer's dividend is firmly in ultra-high-yield territory. Its forward dividend yield tops 6.4%. Pfizer's management sounds ...

Pfizer also offers an attractive dividend yield.” Overall, PFE ranks 5th on our list of most undervalued pot stocks to buy ...

Pfizer's high initial dividend yield, solid ratings, and promising pipeline make it a potentially undervalued investment. See ...

Maintaining dividend aristocrat status isn’t easy, as it requires companies to pay out dividends consistently (and raise them ...

Investors looking for a way to pump up their passive income streams want to turn their attention toward the pharmaceutical ...

This represents a $1.68 annualized dividend and a dividend yield of 6.55%. The ex-dividend date of this dividend is Friday, ...

Pfizer's stock appears undervalued with a high dividend yield of 6.8%, making it a potential long-term investment despite low growth expectations. The company reported strong Q3 results with 31.2% YoY ...

For those looking for great candidates, here are two in the healthcare sector: Merck (NYSE: MRK) and Pfizer (NYSE: PFE). Is ...

The appetite for high-risk investments really increased following Donald Trump’s presidential victory. Indeed, gold — a ...

We recently compiled a list of the Dividend Contenders List: Top 15. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other dividend contenders. Dividend ...